L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for one of the worst pandemics in modern history. Several prevention and treatment strategies have been designed and evaluated in recent months either through the repurposing of existing treatments or the development of new drugs and vaccines. In this study, we show that L-carnitine tartrate supplementation in humans and rodents led to significant decreases of key host dependency factors, notably angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), and Furin, which are responsible for viral attachment, viral spike S-protein cleavage, and priming for viral fusion and entry. Interestingly, pre-treatment of Calu-3, human lung epithelial cells, with L-carnitine tartrate led to a significant and dose-dependent inhibition of the infection by SARS-CoV-2. Infection inhibition coincided with a significant decrease in ACE2 mRNA expression levels. These data suggest that L-carnitine tartrate should be tested with appropriate trials in humans for the possibility to limit SARS-CoV-2 infection.

[1]  Myron S. Cohen,et al.  Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection , 2021, The New England journal of medicine.

[2]  V. Ranieri,et al.  Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations , 2020, Journal of Global Antimicrobial Resistance.

[3]  K. Ita.  Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development , 2020, Archives of Medical Research.

[4]  D. Kendrick,et al.  Covid-19 vaccines: delivering protective immunity , 2020, BMJ.

[5]  Lorenz Förster,et al.  L-carnitine exerts a nutrigenomic effect via direct modulation of nuclear receptor signaling in adipocytes, hepatocytes and SKMC, demonstrating its nutritional impact. , 2020, Nutrition research.

[6]  D. Lei,et al.  Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals , 2020, Nature Microbiology.

[7]  Lawrence O Gostin,et al.  A global survey of potential acceptance of a COVID-19 vaccine , 2020, Nature Medicine.

[8]  M. Beltramello,et al.  Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology , 2020, Cell.

[9]  M. Mansournia,et al.  The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials , 2020, Journal of Diabetes and Metabolic Disorders.

[10]  D. A. Stein,et al.  TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells , 2020, Life Science Alliance.

[11]  M. Müller,et al.  Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2 , 2020, Nature.

[12]  S. Del Prato,et al.  COVID-19 in people with diabetes: understanding the reasons for worse outcomes , 2020, The Lancet Diabetes & Endocrinology.

[13]  J. Hewitt,et al.  The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study , 2020, The Lancet Public Health.

[14]  B. Patel,et al.  Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID‐19 , 2020, Obesity.

[15]  Pankaj Agarwal,et al.  Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study , 2020, BMC Geriatrics.

[16]  Pei-Jer Chen,et al.  Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects , 2020, Cell Reports.

[17]  S. Solomon,et al.  COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease , 2020, European journal of heart failure.

[18]  V. Jhanji,et al.  Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea , 2020, Eye.

[19]  K. Şahin,et al.  A Dose-Dependent Effect of Carnipure® Tartrate Supplementation on Endurance Capacity, Recovery, and Body Composition in an Exercise Rat Model , 2020, Nutrients.

[20]  Katsuhiko Suzuki,et al.  Characterization and Modulation of Systemic Inflammatory Response to Exhaustive Exercise in Relation to Oxidative Stress , 2020, Antioxidants.

[21]  P. Insel,et al.  A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance , 2020, British journal of pharmacology.

[22]  M. Loosemore,et al.  Respiratory health in athletes: facing the COVID-19 challenge , 2020, The Lancet Respiratory Medicine.

[23]  M. Yousefifard,et al.  Antiviral therapy in management of COVID-19: a systematic review on current evidence , 2020, Archives of academic emergency medicine.

[24]  Laurie Tomlinson,et al.  Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic , 2020, Nature Reviews Nephrology.

[25]  Fengxiang Wei,et al.  Epidemiology and Clinical Characteristics of COVID-19. , 2020, Archives of Iranian medicine.

[26]  F. Ruschitzka,et al.  COVID-19 Illness and Heart Failure , 2020, JACC: Heart Failure.

[27]  Hon-Cheong So,et al.  Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits , 2020, Diabetes Care.

[28]  N. Seidah,et al.  Furin cleaves SARS-CoV-2 spike-glycoprotein at S1/S2 and S2'for viral fusion/entry: indirect role for TMPRSS2 , 2020 .

[29]  A. Sitta,et al.  Oxidative damage in mitochondrial fatty acids oxidation disorders patients and the in vitro effect of l-carnitine on DNA damage induced by the accumulated metabolites. , 2019, Archives of biochemistry and biophysics.

[30]  A. Sheikhi,et al.  Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[31]  M. Azadbakht,et al.  L-Carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome. , 2019, Reproduction, fertility, and development.

[32]  E. Russo,et al.  Angiotensin‐converting‐enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review , 2018, Dermatologic therapy.

[33]  J. Wildberger,et al.  Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial , 2017, EBioMedicine.

[34]  R. Fielding,et al.  l-Carnitine Supplementation in Recovery after Exercise , 2018, Nutrients.

[35]  A. C. Simões e Silva,et al.  Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System. , 2017, Protein and peptide letters.

[36]  M. Adeva-Andany,et al.  Significance of l‐carnitine for human health , 2017, IUBMB life.

[37]  F. Sato,et al.  Anti‐adipogenic and antiviral effects of l‐carnitine on hepatitis C virus infection , 2017, Journal of medical virology.

[38]  K. Djafarian,et al.  The effect of (L‐)carnitine on weight loss in adults: a systematic review and meta‐analysis of randomized controlled trials , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[39]  H. Tabibi,et al.  Inflammation and l-carnitine therapy in hemodialysis patients: a review , 2015, Clinical and Experimental Nephrology.

[40]  Y. Kawakami,et al.  Eccentric exercise-induced delayed-onset muscle soreness and changes in markers of muscle damage and inflammation. , 2013, Exercise immunology review.

[41]  Zuo-Feng Zhang,et al.  Associations of ACE Gene Insertion/Deletion Polymorphism, ACE Activity, and ACE mRNA Expression with Hypertension in a Chinese Population , 2013, PloS one.

[42]  A. Shulkes,et al.  Ketosis and appetite-mediating nutrients and hormones after weight loss , 2013, European Journal of Clinical Nutrition.

[43]  T. Raastad,et al.  Delayed leukocytosis and cytokine response to high-force eccentric exercise. , 2005, Medicine and science in sports and exercise.